A novel strategy for the management of cytomegalovirus retinitis in immunocompromised patients using new anti-cytomegalovirus drugs.

Cytovene (ganciclovir) - Roche

Prevymis (letermovir) - Merck (MSD)

Zirgan (ganciclovir ophthalmic gel) - Bausch Health, Thea Laboratories

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/40568190

Enzhong Jin; Heng Miao; Jing Hou; Jiyang Tang; Qiaozhu Zeng; Yaoyao Sun; Yi Cai; Yuou Yao

Jun 26, 2025